Eli Lilly (NYSE: LLY) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive press releases. In one, Lilly announced plans to acquire the farnesoid X ...

In one, Lilly announced plans to acquire the farnesoid X receptor ... On the higher-profile GLP-1 diet drug news, Lilly cut the monthly, four-dose price of: 5 mg Zepbound to $349 per month ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

with the goal of improving lifestyle choices across diet, exercise, sleep, and stress management. LillyDirect also offers direct home delivery of select Lilly medicines through third-party pharmacy ...

INDIANAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Today Eli Lilly and Company (NYSE ... Zepbound should be used with a reduced-calorie diet and increased physical activity. It should not be used ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Eli Lilly and Company (NYSE: LLY) today announced at a press conference in Washington, D.C., plans to bolster its domestic ... It should be used with a reduced-calorie diet and increased physical ...